about
Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.A New Method To Identify Physically Stable Concentration of Amorphous Solid Dispersions (I): Case of Flutamide + Kollidon VA64.Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.Can Storage Time Improve the Physical Stability of Amorphous Pharmaceuticals with Tautomerization Ability Exposed to Compression? The Case of a Chloramphenicol DrugPhysical Stability and Viscoelastic Properties of Co-Amorphous Ezetimibe/Simvastatin SystemThe Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent MethodsImpact of BaTiO(3) nanoparticles on pretransitional effects in liquid crystalline dodecylcyanobiphenylCo-Stabilization of Amorphous Pharmaceuticals-The Case of Nifedipine and NimodipineBroadband dielectric spectroscopy as an experimental alternative to calorimetric determination of the solubility of drugs into polymer matrix: Case of flutamide and various polymeric matrixesPeculiar relaxation dynamics of propylene carbonate derivativesGlass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-Tg ExcipientsInfluence of Polymeric Additive on the Physical Stability and Viscoelastic Properties of AripiprazoleHow does the high pressure affects the solubility of the drug within the polymer matrix in solid dispersion systemsHow can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersionsCompression-Induced Phase Transitions of BicalutamideEnhancement of the Physical Stability of Amorphous Sildenafil in a Binary Mixture, with either a Plasticizing or Antiplasticizing Compound
P50
Q36330615-F5A29E02-BA70-4C3C-A9FD-4445E309B81FQ48189876-4A3F18E2-0804-48D8-9844-C24524423A60Q48272558-8BC9F221-4573-42FE-B66C-287015191F2BQ51747548-A3CD54AE-ED42-46E6-8250-201102719516Q60263611-A4FDB932-2F91-4267-A9C2-66823969545BQ64077444-EE1DC8B9-52E8-45A2-8D0F-635D2BED84E7Q64077469-B49CCF3C-FED2-4482-A20B-CBD9E877E573Q87478001-69BB5AE1-B773-4EA2-8468-4717007D23F5Q88604836-818E85C4-B63E-4A3D-9376-2D8BEF98E2C2Q91291834-A9E3F00D-24B7-4D8D-BD4A-857F854AFFF3Q91309989-137E2702-0B4C-4398-9B7B-D5ADF036C7B4Q91741525-665D1AE0-82C7-4C7C-B03B-5711659C9F80Q92220036-45116CDE-4CE4-4600-8DB3-F090F0ED39ECQ92525787-E11B1339-63C9-420F-A5B8-87E0AEE8F907Q92564620-40F5B1F0-1CAB-4D4A-A747-EA64E2148E53Q94591692-7D39624E-83D7-4F01-9F42-39C6A4C6265FQ95655889-328B62DB-594F-4C9E-8347-D48D6EE9CAA0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Krzysztof Chmiel
@ast
Krzysztof Chmiel
@en
Krzysztof Chmiel
@es
Krzysztof Chmiel
@nl
Krzysztof Chmiel
@pl
type
label
Krzysztof Chmiel
@ast
Krzysztof Chmiel
@en
Krzysztof Chmiel
@es
Krzysztof Chmiel
@nl
Krzysztof Chmiel
@pl
prefLabel
Krzysztof Chmiel
@ast
Krzysztof Chmiel
@en
Krzysztof Chmiel
@es
Krzysztof Chmiel
@nl
Krzysztof Chmiel
@pl
P106
P1153
57147830100
P31
P496
0000-0003-4532-0051